Skip to main content

Table 4 Patients with gametocytes on admission and following treatment with artemether-lumefantrine (AL) artesunate-amodiaquine (ASAQ), by site and year (2007 to 2009)

From: Surveillance of the efficacy of artemether-lumefantrine and artesunate-amodiaquine for the treatment of uncomplicated Plasmodium falciparum among children under five in Togo, 2005-2009

Drug

Site

District

Province

Year

Gametocytes

day 0

day 7

day 14

day 21

day 28

AL

Dapaong

Tone

Savanes

2009

0/82

0/82

0/82

0/80

0/76

AL

Kouvé

Yoto

Maritime

2009

8/84

3/84

1/84

1/84

1/83

AL

Lomé

Lomé

Maritime

2007

0/85

1/81

0/79

0/79

0/76

AL

Niamtougou

Doufelgou

Maritime

2007

9/82

3/81

1/81

0/79

0/71

AL

Sokodé

Tchaoudjo

Centrale

2007

2/82

0/76

0/76

0/76

0/73

ASAQ

Dapaong

Tone

Savanes

2009

0/81

0/81

0/81

0/79

0/76

ASAQ

Kouvé

Yoto

Maritime

2009

7/85

2/85

0/85

0/84

0/84

ASAQ

Lomé

Lomé

Maritime

2007

6/84

3/82

0/82

1/82

0/82

ASAQ

Niamtougou

Doufelgou

Maritime

2007

11/83

7/78

7/79

2/77

0/76

ASAQ

Sokodé

Tchaoudjo

Centrale

2007

5/87

5/83

6/83

2/82

1/81